PBH | tickerfilter.com

Fundamental analysis

51%

Profitability 38%

Dept financing 46%

Liquidity 59%

Performance 64%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-0.43%

1 Month

2.94%

3 Months

14.89%

6 Months

3.37%

1 Year

-18.08%

2 Year

-4.14%

Key data

Stock price

$69.00

P/E Ratio

15.90

DAY RANGE

$66.54 - $69.37

EPS

$3.81

52 WEEK RANGE

$57.25 - $90.04

52 WEEK CHANGE

-$19.28

MARKET CAP

2.966 B

YIELD

N/A

SHARES OUTSTANDING

47.319 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

08-07-2025

BETA

0.50

PUBLIC FLOAT

AVERAGE 10 VOLUME

$485,538

AVERAGE 30 VOLUME

$446,458

Company detail

CEO: Ronald M. Lombardi
Region: US
Website: prestigebrands.com
Employees: 540
IPO year: 2005

Issue type: Common Stock
Market: NYSE
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Prestige Consumer Healthcare Inc. develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies.

PBH - Prestige Consumer Healthcare Inc.